Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
A novel four-step preservation technique allowed the livers of rats to be stored for 3-4 days before transplantation. Could the method transform organ transplantation globally?
Researchers from Georgia Tech have created a wearable computer glove that they say can teach people to read and write braille, even when their attention is elsewhere.
People with low levels of cortisol - the 'stress hormone' - in the afternoon may be less likely to vote in US national elections, according to new research.